Murakawa Y, Strober W, James S P
Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Immunol Res. 1991;10(3-4):441-6. doi: 10.1007/BF02919739.
About one half of circulating human B cells express the Leu-8 peripheral lymph node homing receptor that has been implicated in adhesion of lymphocytes and neutrophils to vascular endothelium. A novel and unique function of the Leu-8 antigen has been found in the present study: anti-Leu-8 monoclonal antibody directly inhibits B cell antibody production induced by SAC + IL-2, without affecting B cell proliferation or other early steps of B cell activation. This effect of anti-Leu-8 is unique in that other antibodies that inhibit B cell differentiation are not selective and also inhibit B cell proliferation. The inhibitory effect is not reversed by addition of T cells, monocytes, or recombinant IL-1 or IL-6 and is not blocked by anti-TGF-beta. Thus, the natural ligand(s) for Leu-8 may be capable of transducing regulatory signals that have a selective effect on B cell differentiation.
循环中的人类B细胞约有一半表达Leu-8外周淋巴结归巢受体,该受体与淋巴细胞和中性粒细胞与血管内皮的黏附有关。本研究发现了Leu-8抗原一种新颖独特的功能:抗Leu-8单克隆抗体可直接抑制由金黄色葡萄球菌A蛋白(SAC)+白细胞介素-2(IL-2)诱导的B细胞抗体产生,而不影响B细胞增殖或B细胞激活的其他早期步骤。抗Leu-8的这种作用是独特的,因为其他抑制B细胞分化的抗体没有选择性,还会抑制B细胞增殖。添加T细胞、单核细胞、重组IL-1或IL-6不能逆转这种抑制作用,抗转化生长因子-β(TGF-β)也不能阻断这种抑制作用。因此,Leu-8的天然配体可能能够转导对B细胞分化有选择性作用的调节信号。